These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 757280

  • 61. [Uricosuric effect of a phenylbutazone derivative, cetophenylbutazone].
    Mugler A.
    Rev Rhum Mal Osteoartic; 1971 Jan; 38(1):33-9. PubMed ID: 5549166
    [No Abstract] [Full Text] [Related]

  • 62. [Gout--based on 110 cases. II].
    Matusan J, Dubravcić M, Tukić A, Boschi S.
    Med Glas; 1968 Dec; 22(12):436-41. PubMed ID: 5199574
    [No Abstract] [Full Text] [Related]

  • 63. [Pathogenesis and therapy of gout].
    Mertz DP.
    Med Klin; 1971 Apr 23; 66(17):623-6. PubMed ID: 4994876
    [No Abstract] [Full Text] [Related]

  • 64. Understanding hyperuricemia: nursing implications.
    Johnson ES.
    Nurs Clin North Am; 1972 Jun 23; 7(2):399-406. PubMed ID: 4482424
    [No Abstract] [Full Text] [Related]

  • 65.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 66.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 67.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 68.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 69. [Clinical experience in long-term treatment of gout with benzofuran iodine and bromine derivatives].
    Masbernard A, Guilbaud J, Droniou J.
    Lyon Med; 1971 Apr 25; 225(8):683-91. PubMed ID: 5089719
    [No Abstract] [Full Text] [Related]

  • 70. Efficacy and tolerability of urate-lowering drugs in gout: a randomised controlled trial of benzbromarone versus probenecid after failure of allopurinol.
    Reinders MK, van Roon EN, Jansen TL, Delsing J, Griep EN, Hoekstra M, van de Laar MA, Brouwers JR.
    Ann Rheum Dis; 2009 Jan 25; 68(1):51-6. PubMed ID: 18250112
    [Abstract] [Full Text] [Related]

  • 71. Febuxostat: new drug. Hyperuricaemia: risk of gout attacks.
    Prescrire Int; 2009 Apr 25; 18(100):63-5. PubMed ID: 19585722
    [Abstract] [Full Text] [Related]

  • 72. [Therapy of chronic gout].
    Ballabio CB, Ligmière GC, Famtiori F, Tosi S, Colombo B.
    Arzneimittelforschung; 1971 Nov 25; 21(11):1857-60. PubMed ID: 5171821
    [No Abstract] [Full Text] [Related]

  • 73. Febuxostat versus allopurinol for gout.
    Gelber AC.
    N Engl J Med; 2006 Apr 06; 354(14):1532-3; author reply 1532-3. PubMed ID: 16602151
    [No Abstract] [Full Text] [Related]

  • 74.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 75. [Uricosuric agent benzbromarone vs. allopurinol: comparable effect].
    Manger B.
    Dtsch Med Wochenschr; 2015 Apr 06; 140(8):562. PubMed ID: 25945905
    [No Abstract] [Full Text] [Related]

  • 76.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 77. Treatment of acute gout--misuse of allopurinol.
    Gow PJ.
    N Z Med J; 1979 Nov 14; 90(647):396. PubMed ID: 293565
    [No Abstract] [Full Text] [Related]

  • 78. The side effects of allopurinol.
    Wallach SL.
    Hosp Pract (1995); 1998 Sep 15; 33(9):22. PubMed ID: 9750548
    [No Abstract] [Full Text] [Related]

  • 79. Diuretics and hyperuricemia.
    Sfikakis P.
    N Engl J Med; 1970 Apr 30; 282(18):1047-8. PubMed ID: 5442901
    [No Abstract] [Full Text] [Related]

  • 80. Allopurinol in the treatment of gout.
    Rundles RW, Metz EN, Silberman HR.
    Ann Intern Med; 1966 Feb 30; 64(2):229-58. PubMed ID: 5322938
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.